Lynn M. Rose, PhD, Joins BRI as First Director of Scientific Administration

Seattle, WA

(Seattle-June 13, 2012) Benaroya Research Institute at Virginia Mason (BRI) recently named Lynn M. Rose, PhD, as the first director of scientific administration. Dr. Rose will be responsible for the oversight of several administrative departments that support science activities at BRI. This includes research compliance activities, clinical research administration and development of intellectual property. 

Dr. Rose’s experience includes more than 30 years in biomedical research in academia and industry. Most recently, she served as research associate professor, Department of Pediatrics, UW School of Medicine, and faculty director of the Preclinical Research and Development Core of the Institute of Translational Health Sciences (ITHS). She was also director, Office of Regulatory and Clinical Affairs, at Seattle Children’s Research Institute, Center for Clinical and Translational Research. She has a strong research background in immunology and autoimmune diseases and began her career as a basic research scientist. Dr. Rose currently serves on the Board of Directors of the Northwest Association for Biomedical Research (NWABR).

“I hope to facilitate the advancement of new therapies for autoimmune diseases,” said Dr. Rose. “With my experience in basic, translational and clinical research, I aim to support scientists in achieving their goals.” BRI is a world leader in these areas, translating research from basic laboratory discoveries to directly help patients suffering from disease.   

About Benaroya Research Institute at Virginia Mason

Benaroya Research Institute at Virginia Mason (BRI), founded in 1956, is an international leader in immune system and autoimmune disease research, translating discoveries to real-life applications. BRI is one of the few research institutes in the world dedicated to discovering causes and cures to eliminate autoimmune diseases such as Type 1 diabetes, multiple sclerosis, arthritis and many others. Visit or Facebook/BenaroyaResearch for more information about BRI, clinical studies and the more than 80 different types of autoimmune diseases.





Learn the Latest

A sample printed newsletterSign up for our news & updates and learn the latest in the fight against autoimmune diseases.

Sign up today